Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance... Show more
Hyperliquid Strategies Inc. is a digital asset treasury company focused on the HYPE token, the native asset of the Hyperliquid Layer-1 blockchain. The company builds and manages its treasury primarily by accumulating HYPE, staking those holdings for yield, operating a validator, and opportunistically repurchasing its own shares. The firm completed a business combination with Sonnet BioTherapeutics and began trading on Nasdaq under the symbol PURR in December 2025.
As one of the largest HYPE-focused treasury vehicles among U.S. public companies, PURR is widely followed as a regulated, exchange-traded proxy for exposure to the Hyperliquid ecosystem. The company has disclosed that its share price is "highly correlated to the price of HYPE tokens," a relationship that has defined its trading behavior in recent months. Its treasury has grown to roughly 38.8 million HYPE tokens, a position worth approximately $2.9 billion at recent prices, alongside a debt-free balance sheet.
Over the trailing 30 days, PURR has declined approximately 11%, moving from a closing price of $12.27 on September 30 to roughly $10.88 in the most recent session. The path was far from linear: shares reached $13.05 on October 5, then fell about 33% to a low near $8.80 during the week of October 23, before a sharp recovery that lifted the stock back above $12 in late October.
The three-month picture tells a different story. From a close near $6.21 at the end of July, PURR has climbed roughly 75%, even after the recent pullback. The shares set an all-time intraday high of $14.14 in late August and have remained well above their mid-year levels, underscoring a powerful multi-month uptrend punctuated by bouts of extreme volatility tied to the HYPE token.
The 30-day decline is best understood through the HYPE token, which is the primary driver of PURR's net asset value. HYPE fell more than 18% during October, underperforming Bitcoin, which declined roughly 6% from its monthly peak. That drawdown pulled PURR from its early-October high to its late-October low as the stock briefly traded below its net asset value.
Regulatory commentary added to the pressure. CME Group (CME) CEO Terry Duffy publicly raised concerns about Hyperliquid's lack of know-your-customer checks and the risks of automatic liquidations on highly leveraged products. The remarks arrived as investors were already reassessing positioning in crypto-linked equities.
Two developments cushioned the decline. First, the board more than tripled its share repurchase authorization from $30 million to $100 million and extended the program's deadline to October 31, 2027, citing confidence in its long-term capital strategy. Second, news that Intercontinental Exchange (ICE), parent of the New York Stock Exchange, planned to partner with Trade.xyz to bring perpetual contracts into the U.S. regulated market sparked a HYPE rally above $94, lifting PURR more than 20% in a single late-October session.
The broader quarterly gain was anchored by strong fundamentals and HYPE appreciation. In late August, the company reported fiscal 2026 results showing net income of about $305.5 million, driven by unrealized gains on HYPE, with roughly $553 million in treasury-related income and $9.5 million in staking and validator revenue. The HYPE treasury more than doubled to 29.3 million tokens, total assets reached about $2.06 billion, and the company carried no debt.
Management expanded its equity facility to $2.5 billion to fund further HYPE accumulation, launched a validator in partnership with Unit Labs, and completed its exit from legacy biotech operations. HYPE's rise to an all-time high near $97.96 amplified the effect, while reported institutional positions from firms including Duquesne Family Office, BlackRock, and State Street reinforced the stock's profile as a liquid vehicle for HYPE exposure.
Tickeron's Trending AI Robots page highlights a curated selection of the platform's most relevant, top-performing AI trading bots. Tickeron offers hundreds of automated trading bots that monitor thousands of tickers, but only the strongest and most relevant strategies appear in this section. The bots vary in trading style, timeframe, and performance metrics, giving users a way to compare different algorithmic approaches to the market. For investors following volatile, catalyst-driven names, the page offers a practical starting point for exploring data-driven trading strategies.
Looking ahead, the most important variable remains the price of HYPE, given PURR's structural correlation to the token. The company's next earnings report is scheduled for December 2, 2026, and investors will watch for updates on treasury size, staking income, and capital deployment. Scheduled HYPE token unlock events in early November could also influence near-term token supply dynamics.
Regulatory developments represent another key theme, including any progress toward a compliant U.S. presence for Hyperliquid and responses to scrutiny around know-your-customer standards and liquidation mechanics. Finally, the execution of the expanded buyback program and the stock's premium or discount to its net asset value will remain closely tracked by market participants.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Be on the lookout for a price bounce soon.
Following a +1.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where PURR advanced for three days, in 39 of 45 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PURR as a result. In 10 of 10 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for PURR turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 7 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
PURR moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PURR crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 1 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PURR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
PURR broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PURR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PURR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.931) is normal, around the industry mean (3.120). P/E Ratio (2.746) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. PURR's P/S Ratio (96.154) is slightly higher than the industry average of (16.899).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PURR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers